Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
Published Online: 2023-04-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Andrew Whitelaw•Andrew Whitelaw•Andrii Dudnyk•Andrii Dudnyk•Anna M Mandalakas•Anna Maria Mandalakas•Barbara Molina-Moya•Barbara Molina-Moya•Berit Lange•Berit Lange•Charles R Horsburgh•Charles Robert Horsburgh•Christian Lienhardt•Christian Lienhardt•Christoph Lange•Christoph Lange•Dumitru Chesov•Dumitru Chesov•Emmanuelle Cambau•Emmanuelle Cambau•Florence Morel•Florence Morel•Florian Maurer•Florian P Maurer•Francesca Conradie•Francesca Conradie•Frank van Leth•Frank van Leth•Irina Kontsevaya•Irina Kontsevaya•Jose Domínguez•José Domínguez•Keertan Dheda•Keertan Dheda•Lorenzo Guglielmetti•Lorenzo Guglielmetti•Maha R Farhat•Maha R. Farhat•Martin J Boeree•Martin J. Boeree•Martin P Grobusch•Martin P. Grobusch•Matthias I Gröschel•Matthias I. Gröschel•Matthias Merker•Matthias Merker•Nicolas Veziris•Nicolas Veziris•Paolo Miotto•Paolo Miotto•Sebastien Gagneux•Sebastien Gagneux•Stefan Niemann•Stefan Niemann•Vivian Cox•Vivian Cox
